Lipoprotein (a) Inhibitors | Kinase Inhibitors on Lipoprotein (a) Signaling Pathways

Lipoprotein (a) Lipoprotein (a)

Inhibitor

Cat.No.	Name	Information
M40648	Muvalaplin	Muvalaplin (LY3473329) is a first-in-class, orally active lipoprotein (a) (Lp(a)) inhibitor that inhibits Lp(a) formation by blocking apolipoprotein apo(a)-apo B100 interactions and avoids interaction with the cognate protein fibrinogen. In addition, Muvalaplin is used in the study of cardiovascular and metabolism-related diseases.

Cat.No.

Name

Information

M40648

Muvalaplin (LY3473329) is a first-in-class, orally active lipoprotein (a) (Lp(a)) inhibitor that inhibits Lp(a) formation by blocking apolipoprotein apo(a)-apo B100 interactions and avoids interaction with the cognate protein fibrinogen. In addition, Muvalaplin is used in the study of cardiovascular and metabolism-related diseases.